| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A common variant associated with prostate cancer in European and African populations
|
Kibel, Adam S.
|
|
2007
|
25 |
5 |
p. 446-447
2 p.
|
article
|
| 2 |
Age at surgery for undescended testis and risk of testicular cancer
|
Penson, David F.
|
|
2007
|
25 |
5 |
p. 440-
1 p.
|
article
|
| 3 |
An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors
|
Kibel, Adam S.
|
|
2007
|
25 |
5 |
p. 450-
1 p.
|
article
|
| 4 |
Biological, translational, and clinical advances in urologic oncology: Sessions of the Society of Urologic Oncology annual meeting, Atlanta, GA, May 2006
|
Reiter, Robert E.
|
|
2007
|
25 |
5 |
p. 396-
1 p.
|
article
|
| 5 |
Contents
|
|
|
2007
|
25 |
5 |
p. vii-viii
nvt p.
|
article
|
| 6 |
Does prostate biopsy Gleason score accurately express the biologic features of prostate cancer?
|
Stav, Kobi
|
|
2007
|
25 |
5 |
p. 383-386
4 p.
|
article
|
| 7 |
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators
|
Trump, Donald L.
|
|
2007
|
25 |
5 |
p. 445-446
2 p.
|
article
|
| 8 |
Editorial Board
|
|
|
2007
|
25 |
5 |
p. v-
1 p.
|
article
|
| 9 |
Erectile function outcome reporting after clinically localized prostate cancer treatment
|
Penson, David F.
|
|
2007
|
25 |
5 |
p. 443-
1 p.
|
article
|
| 10 |
Fundamental advances in the biology of urologic cancer
|
Reiter, Robert E.
|
|
2007
|
25 |
5 |
p. 397-
1 p.
|
article
|
| 11 |
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|
Kibel, Adam S.
|
|
2007
|
25 |
5 |
p. 447-448
2 p.
|
article
|
| 12 |
Incidence trends in primary malignant penile cancer
|
Barnholtz-Sloan, Jill S.
|
|
2007
|
25 |
5 |
p. 361-367
7 p.
|
article
|
| 13 |
Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens
|
Divrik, Rauf Taner
|
|
2007
|
25 |
5 |
p. 376-382
7 p.
|
article
|
| 14 |
Inflammation, atrophy, and prostate carcinogenesis
|
De Marzo, Angelo M.
|
|
2007
|
25 |
5 |
p. 398-400
3 p.
|
article
|
| 15 |
Information for Authors
|
|
|
2007
|
25 |
5 |
p. IBC-
1 p.
|
article
|
| 16 |
Integrative molecular concept modeling of prostate cancer progression
|
Kibel, Adam S.
|
|
2007
|
25 |
5 |
p. 449-450
2 p.
|
article
|
| 17 |
Masthead
|
|
|
2007
|
25 |
5 |
p. iv-
1 p.
|
article
|
| 18 |
Micro-RNA profiling in kidney and bladder cancers
|
Gottardo, Fedra
|
|
2007
|
25 |
5 |
p. 387-392
6 p.
|
article
|
| 19 |
On the importance of race, socioeconomic status, and comorbidity when evaluating quality of life in men with prostate cancer
|
Penson, David F.
|
|
2007
|
25 |
5 |
p. 441-442
2 p.
|
article
|
| 20 |
Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis
|
Bonfil, R. Daniel
|
|
2007
|
25 |
5 |
p. 407-411
5 p.
|
article
|
| 21 |
Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer
|
Penson, David F.
|
|
2007
|
25 |
5 |
p. 442-443
2 p.
|
article
|
| 22 |
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer
|
Trump, Donald L.
|
|
2007
|
25 |
5 |
p. 446-
1 p.
|
article
|
| 23 |
RhoGDI2: A new metastasis suppressor gene: Discovery and clinical translation
|
Harding, Michael A.
|
|
2007
|
25 |
5 |
p. 401-406
6 p.
|
article
|
| 24 |
1. Sorafenib in advanced clear-cell renal-cell carcinoma
|
Trump, Donald L.
|
|
2007
|
25 |
5 |
p. 443-445
3 p.
|
article
|
| 25 |
Survey Section Editorial Board
|
|
|
2007
|
25 |
5 |
p. 439-
1 p.
|
article
|
| 26 |
Survival associated with treatment vs. observation of localized prostate cancer in elderly men
|
Penson, David F.
|
|
2007
|
25 |
5 |
p. 440-441
2 p.
|
article
|
| 27 |
Targeted therapies for kidney cancer in urologic practice
|
Haas, Naomi B.
|
|
2007
|
25 |
5 |
p. 420-432
13 p.
|
article
|
| 28 |
Targeted therapies in bladder cancer—an update
|
Black, Peter C.
|
|
2007
|
25 |
5 |
p. 433-438
6 p.
|
article
|
| 29 |
The burden of illness associated with renal cell carcinoma in the United States
|
Lang, Kathleen
|
|
2007
|
25 |
5 |
p. 368-375
8 p.
|
article
|
| 30 |
Therapeutic options for hormone-refractory prostate cancer in 2007
|
Hadaschik, Boris A.
|
|
2007
|
25 |
5 |
p. 413-419
7 p.
|
article
|
| 31 |
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
|
Kibel, Adam S.
|
|
2007
|
25 |
5 |
p. 448-449
2 p.
|
article
|
| 32 |
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
|
Kibel, Adam S.
|
|
2007
|
25 |
5 |
p. 448-
1 p.
|
article
|
| 33 |
Translational advances in urologic cancer
|
Reiter, Robert E.
|
|
2007
|
25 |
5 |
p. 412-
1 p.
|
article
|
| 34 |
Ureteral tumor thrombus from renal cell carcinoma extending into bladder
|
Gulati, Mittul
|
|
2007
|
25 |
5 |
p. 393-395
3 p.
|
article
|
Journal description